Dr. Schwab is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 W Arbor Dr
San Diego, CA 92103Phone(858) 249-3781
Fax(858) 249-3250- Is this information wrong?
Summary
- I am a medical oncologist specializing in the treatment of patients with breast cancer, treating women with endocrine therapy and/or chemotherapy, as needed.
I am an active clinical trial investigator with major roles in the novel I-SPY2 multicenter trial. I co-chair the safety committee and act as a medical monitor for the trial.
Education & Training
University of California San DiegoFellowship, Hematology/Oncology, 2003 - 2006
University of California San DiegoResidency, Internal Medicine, 2000 - 2003
Albert Einstein College of MedicineClass of 2000- UC BerkeleyBA, Molecular Cell Biology, 1991 - 1995
Certifications & Licensure
CA State Medical License 2001 - 2021- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Early Clinical Trials Award “A Biomarker Study of Mifepristone in Early Stage Breast Cancer.” UCSD Moores Cancer Center, 2010-2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01Andres Forero, MD, Donald Northfelt, MD, Julie Lang, MD, Anne Wallace, MD, Debasish Tripathy, MD, Amy Jo Chien, MD, Anthony Elias, MD, Minetta Liu, MD, Rita Nanda, MD, Kathy Albain, MD, Qamar Khan, MD, Do...
Publications & Presentations
PubMed
- Exploring the landscape of focal amplifications in cancer using AmpliconArchitectViraj Deshpande, Jens Luebeck, Nam-phuong D. Nguyen, Mehrdad Bakhtiari, Kristen M. Turner, Richard J. Schwab, Hannah Carter, Paul S. Mischel, Vineet Bafna> ;Nature Communications. 2019 Jan 23
- Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanc...Shumei Kato, Ryosuke Okamura, Manvita Mareboina, Suzanna Lee, Aaron M. Goodman, Sandip Pravin Patel, Paul T. Fanta, Richard J. Schwab, Peter Vu, Victoria M. Raymond, R...> ;JCO precision oncology. 2019 Jan 22
- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.Suping Zhang, Han Zhang, Emanuela M. Ghia, Jiajia Huang, Liufeng Wu, Jianchao Zhang, Sharon M. Lam, Yang Lei, Jinsong He, Bing Cui, George F. Widhopf, Jian Yu, Richard...> ;Proceedings of the National Academy of Sciences of the United States of America. 2019 Jan 22
- Join now to see all
Press Mentions
Talking Breast Cancer for Men’s Health Awareness WeekJune 15, 2017 10:50
Molecular Tumor Board Helps in Advanced Cancer CasesFebruary 10, 2016 15:58
Committees
- Clinic Medical Director, UC San Diego Moores Cancer Center 2016 - Present
- UCSD Chair, Internal Advisory Committee, SDSU/UCSD Cancer Center Comprehensive Partnership 2016 - Present
- Occult Primary, NCCN Guidelines Committee Member 2014 - Present
- OPT-822 (Globo H-KLH) Phase II/III Study, Steering Committee Member 2012 - Present
Hospital Affiliations
UC San Diego Medical Center – HillcrestSan Diego, California
External Links
- UC San Diego Healthhttp://providers.ucsd.edu/details/11447/richard-schwab-cancer-hematology_blood_diseases-la_jolla
- UC San Diegohttp://profiles.ucsd.edu/richard.schwab
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
